| Not Yet Recruiting | Dialysate Cooling for the Preservation of Cognitive Function in People Receiving Haemodialysis NCT07377500 | University Hospitals of Derby and Burton NHS Foundation Trust | N/A |
| Recruiting | Renal and Hepatic Abnormal Doppler Patterns in Trauma NCT07492511 | Azienda Usl di Bologna | — |
| Not Yet Recruiting | Older Kidney Patient Optimisation Pretransplant NCT07419945 | Guy's and St Thomas' NHS Foundation Trust | N/A |
| Not Yet Recruiting | Kidney Transplant Improvement Through New Exercise Training to Increase Capacity NCT07446296 | University of Pennsylvania | N/A |
| Recruiting | A Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplant NCT06243731 | Takeda | — |
| Enrolling By Invitation | Worldwide Assessment of Deceased Donor Kidney Utilization NCT07341516 | Paris Translational Research Center for Organ Transplantation | — |
| Not Yet Recruiting | Use of New Drug QRX-3 for Prevention and Treatment of Chronic Kidney Disease Progression NCT06866236 | Ebima Clifford Okundaye | Phase 2 / Phase 3 |
| Recruiting | STarting incrEmental Prescription of Peritoneal Dialysis NCT06642597 | The University of Queensland | N/A |
| Not Yet Recruiting | Levocarnitine for Reducing ESA Requirements in Hemodialysis Patients With Renal Anemia NCT07160452 | Shaikh Zayed Hospital, Lahore | Phase 4 |
| Recruiting | A High Protein Egg White Pudding for People With Kidney Failure (HiPE KF) NCT06343727 | Seven Oaks Hospital Chronic Disease Innovation Centre | N/A |
| Recruiting | CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk NCT07053462 | AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC | Phase 1 / Phase 2 |
| Recruiting | Tolerance Through Mixed Chimerism (Sip-Tego) NCT06972069 | Tatsuo Kawai, MD, PhD | EARLY_Phase 1 |
| Recruiting | Amino Acid Loss During Continuous Renal Replacement Therapy NCT06659835 | Medical University of Vienna | — |
| Recruiting | Deceased Donor Bladder or Combined Kidney-bladder Transplantation: a Phase 0 First-in-human Study NCT06337942 | University of California, Los Angeles | N/A |
| Not Yet Recruiting | Preventing Delayed Graft Function in Kidney Transplant Patients NCT06724211 | University Health Network, Toronto | N/A |
| Not Yet Recruiting | Effects of Homemade Oral Nutrition Supplements for Patients on Hemodialysis With Protein-energy Wasting NCT06569732 | Universiti Malaysia Sabah | N/A |
| Completed | Application and Impact Assessment of Ultrasound Super-Resolution Blood Flow Imaging (URM) in Patients With Ren NCT07484308 | Ma Zhe | N/A |
| Not Yet Recruiting | Predicting Adverse Kidney Events of Cardiac Surgery-Associated Acute Kidney Injury Using Novel Biomarkers NCT06351813 | Shanghai Zhongshan Hospital | — |
| Recruiting | Multifactorial Intervention to Reduce Cardiovascular Disease in Type 1 Diabetes NCT06082063 | Steno Diabetes Center Copenhagen | Phase 3 |
| Recruiting | CAR-T Cell Therapy for Desensitization in Kidney Transplantation NCT06056102 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 |
| Unknown | Short-course Rifamycin-based Regimens for Latent Tuberculosis in Patients With End-stage Kidney Disease NCT05021731 | Miguel Santín | Phase 4 |
| Recruiting | Erector Spinae Plane Block vs Quadratus Lumborum Block for Laparoscopic Nephrectomy NCT06298227 | Istanbul Medipol University Hospital | N/A |
| Completed | Erector Spinae Plane Block in Kidney Transplant Pain Management NCT07369323 | Dr. Lutfi Kirdar Kartal Training and Research Hospital | N/A |
| Recruiting | The Effect of Daratumumab in Patients with Monoclonal Gammopathy of Renal Significance (MGRS) in Finland NCT06889948 | Helsinki University Central Hospital | Phase 2 |
| Completed | Using Shared Decision Making to Improve Kidney Transplantation Rates NCT06141499 | Columbia University | N/A |
| Unknown | Detecting Fluid Accumulation With a Wearable Bioimpedance Sensor NCT06053710 | Mode Sensors AS | N/A |
| Active Not Recruiting | Delayed Tolerance Through Mixed Chimerism NCT05900401 | Massachusetts General Hospital | Phase 1 / Phase 2 |
| Active Not Recruiting | Effect of Intradialytic Exercise on Left Ventricular Diastolic Function in Hemodialysis Patients NCT06584734 | Instituto Nacional de Cardiologia Ignacio Chavez | N/A |
| Completed | Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD NCT05614115 | University of Utah | Phase 1 |
| Completed | Feasibility Testing a shareD dEciSIon Making Intervention for People With Kidney failuRE, Their Relatives, and NCT05842772 | University of Aarhus | N/A |
| Completed | Study of MB-102 (Relmapirazin) and the Use of the MediBeacon® Transdermal GFR Measurement System Using the TGF NCT05777174 | MediBeacon | Phase 3 |
| Completed | A Bioequivalence and Efficacy Study of MB-102 (Relmapirazin) in Chinese Participants NCT05943977 | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Phase 3 |
| Recruiting | Shingrix in Renal Transplant Recipients NCT04128189 | University of Colorado, Denver | Phase 3 |
| Completed | Enhancing the Cardiovascular Safety of Hemodialysis Care (Dialysafe) NCT03171545 | University of Michigan | N/A |
| Completed | Vascular Calcifications in Kidney Transplant Recipient NCT05697458 | Clinical Hospital Center Rijeka | — |
| Enrolling By Invitation | The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in NCT05374291 | University Medical Center Groningen | Phase 3 |
| Completed | SGLT2 Inhibition in Hemodialysis NCT05179668 | Medical University of Vienna | Phase 2 |
| Recruiting | INCremental Dialysis to Improve Health Outcomes in People Starting Haemodialysis (INCH-HD) NCT04932148 | The University of Queensland | N/A |
| Recruiting | DAPAgliflozin for Renal Protection in Heart Transplant Recipients NCT05321706 | Oslo University Hospital | Phase 3 |
| Unknown | Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation NCT05031052 | Charite University, Berlin, Germany | N/A |
| Active Not Recruiting | Clinical Impact of the IBox As an Early Intervention TooL NCT05112315 | Predict4Health | N/A |
| Completed | Monitoring of Hydration Status in Chronic Hemodialysis Patients NCT06798272 | Medical University of Lodz | N/A |
| Active Not Recruiting | Nanoparticle for DSA Removal NCT04277377 | University of Zurich | — |
| Completed | Honoring Individual Goals and Hopes: Implementing Advance Care Planning for Persons With Kidney Disease on Dia NCT05324878 | George Washington University | — |
| Completed | Pilot Study : FreeStyle Libre Pro Flash Continuous Glucose Monitoring System in Subjects With Diabetes on Hemo NCT04641650 | Centre Hospitalier Saint Joseph Saint Luc de Lyon | — |
| Terminated | QUICKly Eradicate Hepatitis C in Patients Undergoing REnal Transplant With 4 Weeks of Glecaprevir/Pibrentasvir NCT04515797 | Massachusetts General Hospital | Phase 4 |
| Unknown | Validation of Arterio Venous Access Stage (AVAS) Classification NCT04796558 | Vascular surgery, University hospital Královské Vinohrady, Prague | — |
| Recruiting | Effects of the SGLT2 Inhibitor Empagliflozin in Patients With Euvolemic and Hypervolemic Hyponatremia NCT04447911 | University Hospital, Basel, Switzerland | Phase 4 |
| Terminated | The WavelinQ™ Arterio-Venous Endovascular Fistula: A Global, Post-Market Investigation NCT04626427 | C. R. Bard | N/A |
| Recruiting | A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access i NCT04671771 | W.L.Gore & Associates | N/A |
| Unknown | CINRYZE as a Donor Pre-treatment Strategy in Kidney Recipients of KDPI>60% NCT02435732 | University of Wisconsin, Madison | Phase 1 |
| Terminated | Personalization of Immunosuppressive Treatment for Organ Transplant Recipients NCT05747053 | George Washington University | — |
| Completed | Evaluate the Safety, Tolerability, and PK of EP547 in Healthy Subjects and Subjects With Cholestatic or Uremic NCT04510090 | Escient Pharmaceuticals, Inc | Phase 1 |
| Withdrawn | HCV + to HCV - Kidney Transplant NCT04320290 | Massachusetts General Hospital | Phase 4 |
| Active Not Recruiting | Hepatitis C Virus (HCV) Positive Kidney Grafts in HCV Negative Recipients NCT04605679 | Loma Linda University | N/A |
| Unknown | Evaluation of Paclitaxel Coated Balloon in the Treatment of Dialysis Access Dysfunction NCT04988789 | Singapore General Hospital | — |
| Withdrawn | Does Terlipressin Improve Renal Outcome After Liver Surgery NCT02368249 | University of Zurich | Phase 2 |
| Terminated | Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney NCT04258423 | Indiana University | Phase 3 |
| Terminated | Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease NCT03840343 | Mayo Clinic | Phase 1 |
| Completed | BIS-guided Fluid Management in HD Patients NCT05272800 | Catholic University of Pelotas | N/A |
| Completed | A Brief Mindful Drinking/Eating Intervention for Hemodialysis Patients With Fluid Restrictions NCT04016311 | University of Texas at Austin | N/A |
| Unknown | RUCONEST® as a Therapeutic Strategy to Reduce the Incidence of Delayed Graft Function NCT03791476 | University of Wisconsin, Madison | Phase 1 |
| Completed | Prefistula Forearm Exercise in Pts Requiring Chronic HD Therapy NCT03988270 | Wake Forest University Health Sciences | N/A |
| Recruiting | Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas) NCT03627013 | Dr. F. Köhler Chemie GmbH | Phase 3 |
| Terminated | Everolimus Monotherapy as Immunosuppression After Liver Transplant NCT04063865 | Indiana University | Phase 3 |
| Recruiting | APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO) NCT03615235 | Wake Forest University Health Sciences | — |
| Completed | FREquent DIalysis & Markers of Cardiac Strain and Injury, Physical Fitness, Habitual Physical Activity & Quali NCT03925454 | Portsmouth Hospitals NHS Trust | — |
| Unknown | The Inflammatory Burden in Hemodialysis vs. Peritoneal Dialysis Patients: the Role of Alpha-defensin NCT03845530 | Hillel Yaffe Medical Center | N/A |
| Withdrawn | Direct Acting Antiviral Therapy in Donor HCV-positive to Recipient HCV-negative Kidney Transplant NCT03623568 | Raymond T. Chung, MD | Phase 4 |
| Completed | Prognosis Study of Renal Transplantation in Children NCT03708094 | Children's Hospital of Fudan University | — |
| Completed | Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis NCT03836508 | Sisli Hamidiye Etfal Training and Research Hospital | N/A |
| Completed | Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre NCT04261205 | Centre Hospitalier Universitaire de Nīmes | — |
| Completed | Development of Antibodies Against Transplant Kidney After Infection NCT06040684 | University Hospital Ostrava | — |
| Completed | A Study of Experimental Medication BMS-986231 in Patients With Different Levels of Kidney Function NCT03332186 | Bristol-Myers Squibb | Phase 1 |
| Unknown | Does Incremental Initiation of Haemodialysis Preserve Native Kidney Function? NCT03418181 | East and North Hertfordshire NHS Trust | N/A |
| Completed | VasQ External Support for Arteriovenous Fistula NCT03242343 | Laminate Medical Technologies | N/A |
| Terminated | Effect of Lost Wage Reimbursement to Kidney Donors on Living Donation Rates NCT03350269 | Arbor Research Collaborative for Health | N/A |
| Unknown | Effects of Exercise and Exercise Counselling in Hemodialysis Patients. NCT03334123 | University Medical Centre Ljubljana | N/A |
| Completed | Clearance and Pharmacokinetics of Antibiotics in Renal Replacement Therapy NCT03714789 | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | — |
| Completed | Enhance Access to Kidney Transplantation and Living Kidney Donation NCT03329521 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | N/A |
| Completed | Kidney Transplant Outcome and Organ Acceptance Practice Pattern: A Nationwide Analyses in the US and France NCT03723668 | Paris Translational Research Center for Organ Transplantation | — |
| Active Not Recruiting | Expanding Live Donor Kidney Transplantation Through Advocacy Training and Social Media NCT03099434 | Johns Hopkins University | N/A |
| Completed | Clotting With Different Dialyzer Membranes NCT02546037 | University College, London | — |
| Completed | New Biomarkers in Heart- and Renal Failure NCT02830464 | RWTH Aachen University | — |
| Completed | A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients NCT02607111 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Phase 4 |
| Completed | Ultrasound Assessment of Volume in Patients on Continuous Dialysis NCT03194750 | University of Alabama at Birmingham | N/A |
| Completed | Acute Effects of Intradialytic Exercise on Cardiovascular Function in Hemodialysis Patients NCT02753868 | University of Illinois at Urbana-Champaign | N/A |
| Unknown | Hemodialysis in the Elderly (70yrs & Older) NCT03065972 | E. Peden, MD | N/A |
| Completed | Healthy.io Method Comparison & User Performance Study NCT02785445 | Healthy.io Ltd. | N/A |
| Unknown | Different Dialysis Modalities and Diet on Gastrointestinal Biome and Azotaemic Toxins NCT04714853 | University College, London | — |
| Unknown | To Assess Ear Blood Flow During Dialysis NCT02545920 | University College, London | — |
| Completed | Immune Monitoring in Sensitized Patients at Risk of Rejection NCT03794817 | University of California, San Francisco | — |
| Unknown | Prospective Study of Urinary Markers of Fibrosis in Kidney Transplants NCT01982903 | Universitaire Ziekenhuizen KU Leuven | — |
| Unknown | Thymoglobulin Induction Therapy in Kidney Transplantation (6mg/kg vs 4mg/kg) NCT02447822 | Asan Medical Center | Phase 4 |
| Terminated | NIRS as a Continuous Noninvasive Monitoring System of Liver/Kidney Graft Perfusion NCT02343016 | Mariella Enoc | — |
| Completed | Post-transplant Cancer Incidence and Survival in Patients With or Without Pre-transplant Cancer NCT02491580 | Uppsala University | — |
| Completed | C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI NCT02134314 | Cedars-Sinai Medical Center | Phase 1 / Phase 2 |
| Completed | IV Antibiotics With Lavage for Severe PD Peritonitis NCT02926846 | Alice Ho Miu Ling Nethersole Hospital | Phase 4 |
| Unknown | Mobilising Lower Limb Fluid for Hemodynamic Stability in Haemodialysis NCT02450474 | The Leeds Teaching Hospitals NHS Trust | N/A |
| Completed | Blood Volume Analysis and Renal Outcomes in Hemodialysis NCT02717533 | VA New York Harbor Healthcare System | — |
| Terminated | Protocolized Diuretic Strategy in Cardiorenal Failure NCT01921829 | Kelly V. Liang, MD | Phase 4 |
| Completed | A Retrospective Multicenter Study to Determine 5-Year Clinical Outcomes in Subjects Previously Enrolled in the NCT01974999 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Completed | Virtual Ward for Home Dialysis NCT01912001 | Christopher Chan | N/A |
| Completed | Quantitative Mass Transfer of SFP-iron From Dialysate to Blood in CKD-HD Patients NCT01894906 | Rockwell Medical Technologies, Inc. | Phase 1 / Phase 2 |
| Completed | Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibr NCT01860183 | Clinical Hospital Merkur | Phase 4 |
| Completed | The Drug Induced Renal Injury Consortium NCT02159209 | Ravindra Mehta | — |
| Terminated | Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol NCT01725113 | Winthrop University Hospital | Phase 4 |
| Completed | Eculizumab for Prevention and Treatment of Kidney Graft Reperfusion Injury NCT01756508 | Russian Academy of Medical Sciences | Phase 2 |
| Completed | A Long-Term Safety Extension Trial of Ferric Citrate in Patients With End-Stage Renal Disease (ESRD) on Dialys NCT01554982 | Keryx Biopharmaceuticals | Phase 3 |
| Completed | Intraoperative Fluid Therapy for Deceased Donor Renal Transplantation NCT02512731 | University Health Network, Toronto | N/A |
| Unknown | Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment i NCT01595984 | Centre Hospitalier Universitaire, Amiens | Phase 3 |
| Completed | Indicating Direction and Angle for Cannulating of AV-fistula in Hemodialysis Patients NCT01536548 | Norwegian University of Science and Technology | N/A |
| Completed | Mesenchymal Stem Cells After Renal or Liver Transplantation NCT01429038 | University of Liege | Phase 1 / Phase 2 |
| Completed | Maximizing Native Arteriovenous Fistulae Rates. NCT02705417 | Medifil AE | — |
| Completed | Safety and Efficacy Study of the Venous Window Needle Guide to Access Arteriovenous (AV)Fistulae NCT01471041 | Vital Access Corp. | Phase 2 / Phase 3 |
| Unknown | Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejecti NCT01446484 | Pirogov Russian National Research Medical University | Phase 1 / Phase 2 |
| Completed | Erythropoietin (EPO) to Protect Renal Function After Cardiac Surgery NCT01423955 | Region Skane | Phase 2 |
| Terminated | Observational Study of Blood Pressure Measurements and Continuous Dialysis NCT01286506 | University of Chicago | — |
| Completed | A 58-Week Safety and Efficacy Trial of Ferric Citrate in Patients With ESRD on Dialysis NCT01191255 | Keryx Biopharmaceuticals | Phase 3 |
| Completed | Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. NCT01231438 | Helse Stavanger HF | Phase 2 |
| Completed | Donor Simvastatin Treatment in Organ Transplantation NCT01160978 | Helsinki University Central Hospital | Phase 2 / Phase 3 |
| Completed | Cinacalcet Versus Parathyroidectomy in Peritoneal Dialysis Patients NCT01447368 | The University of Hong Kong | Phase 4 |
| Completed | Effect of Remote Ischaemic Preconditioning on Renal Function in Patients Undergoing Living Donor Kidney Transp NCT01289548 | Huazhong University of Science and Technology | N/A |
| Completed | Safety Trial of Single Versus Multiple Dose Thymoglobulin Induction in Kidney Transplantation NCT00906204 | Wright State University | Phase 2 |
| Completed | Live Kidney Donor Study -Renal Function Study NCT01158742 | National Institute of Allergy and Infectious Diseases (NIAID) | — |
| Terminated | Desensitization of Highly Sensitized Deceased Donor Renal Transplantation Candidates NCT00986947 | Johns Hopkins University | Phase 2 |
| Terminated | Safety and Efficacy Study of Add On Aliskiren in Patients With Heart Failure and Renal Impairment NCT00881439 | University Medical Center Groningen | Phase 2 |
| Completed | Non Invasive External Monitoring in Dialysis Patients NCT00919438 | Corventis, Inc. | — |
| Unknown | Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure NCT00806039 | Saint Louis VA Medical Center | N/A |
| Completed | Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administra NCT00744939 | Bayer | — |
| Withdrawn | Renal Function in Adults With Congenital Heart Disease. NCT00807274 | Royal Brompton & Harefield NHS Foundation Trust | — |
| Completed | Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patie NCT00765661 | Veloxis Pharmaceuticals | Phase 2 |
| Completed | 1-deamino 8-d-arginine Vasopressin (DDAVP) in Percutaneous Ultrasound-guided Renal Biopsy NCT00748072 | University of Bari | Phase 4 |
| Completed | European Trial of Free Light Chain Removal by Extended Haemodialysis in Cast Nephropathy NCT00700531 | University Hospital Birmingham | N/A |
| Completed | Cardiovascular-Renal Consequences of Reducing Renal Mass After Living Kidney Donation NCT01564966 | Istanbul University | — |
| Withdrawn | Phosphorus and Calcium Removal During Long Hemodialysis Treatment Sessions NCT00633308 | Indiana University | Phase 2 |
| Terminated | Induction of Donor Specific Tolerance in Recipients of Living Kidney Allografts by Donor FCRx Infusion NCT00497926 | Talaris Therapeutics Inc. | Phase 2 |
| Unknown | Far Infrared Treatment for Kidney Diseases NCT00599391 | GAAD Medical Research Institute Inc. | Phase 1 |
| Completed | Effect of Epoetin Beta on Renal Function Within 30 Days Following a Kidney Transplant NCT00815867 | Centre Hospitalier Universitaire, Amiens | Phase 3 |
| Completed | Erythropoietin Resistance in Anemia of Chronic Kidney Disease NCT00526747 | Duke University | — |
| Completed | Testosterone Replacement Therapy in Advanced Chronic Kidney Disease NCT00645658 | Palo Alto Veterans Institute for Research | N/A |
| Completed | Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients NCT00551655 | AIDS Arms Inc. | — |
| Terminated | Hemodilution and Outcome in Cardiac Surgery NCT00364494 | Università Vita-Salute San Raffaele | N/A |
| Terminated | Dynepo Infrequent Dosing Study NCT00450333 | Shire | Phase 3 |
| Completed | Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Re NCT00369382 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Study Evaluating Sirolimus in the Treatment of Kidney Transplant NCT00282217 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Angiotensin Converting Enzyme Inhibitors & Contrast Induced Nephropathy in Patients Receiving a Cardiac Cathet NCT00317252 | Hamilton Health Sciences Corporation | Phase 2 |
| Completed | Validation of Serum Creatinine Dosage and Renal Clearance NCT00323128 | University Hospital, Ghent | Phase 1 |
| Terminated | Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Trans NCT00311311 | Pfizer | Phase 3 |
| Completed | Comparison of Bovine Carotid Artery and Expanded Polytetrafluoroethylene (ePTFE) for Permanent Hemodialysis Ac NCT01021839 | Massachusetts General Hospital | N/A |
| Terminated | COOL RCN: Cooling to Prevent Radiocontrast Nephropathy NCT00306306 | Radiant Medical | Phase 2 / Phase 3 |
| Completed | Effect of Paricalcitol on Markers of Inflammation in Hemodialysis Patients NCT00294866 | Fresenius Medical Care North America | Phase 4 |
| Unknown | Vitamin Metabolism in Kidney Disease NCT00257439 | Aalborg University Hospital | — |
| Terminated | The Boston Scientific ACCESS Trial NCT00260728 | Maquet Cardiovascular | Phase 2 / Phase 3 |
| Completed | CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation NCT00246129 | EMagnusson | Phase 4 |
| Unknown | Hemodialysis Without Anticoagulation in Intensive Care Unit NCT00242398 | Centre Hospitalier Départemental | Phase 3 |
| Completed | A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients NCT00195429 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Unknown | The Study of Infection and Cell Inflammation in Peritoneal Dialysate NCT00173485 | National Taiwan University Hospital | — |
| Terminated | An Open-Label Study To Assess The Pharmacokinetics, Safety And Toleration Of Vfend®; Following Multiple Dosing NCT00150319 | Pfizer | Phase 1 / Phase 2 |
| Completed | EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) NCT00211978 | Nabi Biopharmaceuticals | Phase 3 |
| Completed | NASPI: N-Acetylcysteine vs. Ascorbic Acid for Prevention of Contrast Induced Nephropathy in Renal Insufficienc NCT00356954 | Seoul National University Hospital | Phase 4 |
| Completed | PROMISS: Simvastatin Prevents the Contrast Induced Acute Renal Failure in Patients With Renal Insufficiency Un NCT00259441 | Seoul National University Hospital | Phase 4 |
| Completed | Study Evaluating Sirolimus in Kidney Transplant Recipients. NCT00167947 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Completed | Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients NCT00183248 | University of Miami | Phase 1 / Phase 2 |
| Completed | Iron Sucrose in Stage 3/4 Kidney Disease NCT00202345 | Melbourne Health | Phase 3 |
| Completed | Correction of Anaemia and Progression of Renal Failure on Transplanted Patients NCT00396435 | Centre Hospitalier Universitaire, Amiens | Phase 4 |
| Completed | Study Evaluating Sirolimus in Kidney Transplant Recipients in India NCT00195481 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | Resistive Index Measurements After Kidney Transplantation NCT01879124 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant R NCT00266123 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Recruiting | BIOBANK Renal Transplantation University Hospitals Leuven NCT01331668 | Universitaire Ziekenhuizen KU Leuven | — |
| Completed | Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Takin NCT00195468 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Completed | RECOVER:Comparison of Renal Toxicity Between Visipaque(Iodixanol)and Hexabrix(Ioxaglate)in Renal Insufficiency NCT00247325 | Seoul National University Hospital | Phase 4 |
| Completed | Acetylcysteine in the Prevention of Renal Failure After Bypass Surgery NCT00211653 | Minneapolis Veterans Affairs Medical Center | Phase 1 / Phase 2 |
| Completed | Clopidogrel Prevention of Early Arteriovenous (AV) Fistula Thrombosis NCT03289520 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | Aggrenox Prevention of Access Stenosis NCT00067119 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 3 |
| Completed | AKIN Criteria: Acute Kidney Injury After On-Pump Coronary Artery Bypass Graft (CABG) NCT00780845 | Hospital de Base | — |
| Completed | Study Evaluating Two Different Sirolimus-based Immunosuppressive Regimens in Elderly Kidney Transplant Recipie NCT00254709 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |
| Terminated | The Effect of Isoflurane or Sevoflurane on Kidney Function NCT00144118 | Austin Health | Phase 4 |
| Completed | Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Rena NCT00273871 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 3 |
| Terminated | Tc-99m Renography and Cisplatin-induced Nephrotoxicity NCT00213642 | University Hospital, Rouen | — |
| Completed | Sirolimus and Thymoglobulin to Prevent Kidney Transplant Rejection NCT00006178 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Terminated | Search for New Methods to Detect Acute Renal Failure NCT00026702 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | Stenting in Renal Dysfunction Caused by Atherosclerotic Renal Artery Stenosis NCT00150943 | UMC Utrecht | Phase 3 |
| Completed | Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients NCT00213590 | University Hospital, Rouen | Phase 3 |
| Completed | Pirfenidone to Treat Kidney Disease (Focal Segmental Glomerulosclerosis) NCT00001959 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Phase 2 |
| Completed | Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant NCT00001859 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | — |
| Completed | A Safety and Efficacy Study for Epoetin Alfa in Pre-dialysis Subjects. NCT00364260 | Janssen-Ortho Inc., Canada | Phase 3 |
| Active Not Recruiting | Genetic Causes of FSGS, Nephrotic Syndrome, or Kidney Failure NCT02194582 | Beth Israel Deaconess Medical Center | — |
| Unknown | Prospective Controlled Study of Posttransplant Diabetes NCT00006331 | National Center for Research Resources (NCRR) | — |
| Unknown | Urinary Marker for Oxidative Stress in Human Cisplatin- Induced Renal Injury NCT00310739 | Hamamatsu University | — |
| Completed | Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients NCT00261820 | Wyeth is now a wholly owned subsidiary of Pfizer | Phase 4 |